Your browser doesn't support javascript.
loading
Characteristics of Salmonella Recovered From Stools of Children Enrolled in the Global Enteric Multicenter Study.
Kasumba, Irene N; Pulford, Caisey V; Perez-Sepulveda, Blanca M; Sen, Sunil; Sayed, Nurulla; Permala-Booth, Jasnehta; Livio, Sofie; Heavens, Darren; Low, Ross; Hall, Neil; Roose, Anna; Powell, Helen; Farag, Tamer; Panchalingham, Sandra; Berkeley, Lynette; Nasrin, Dilruba; Blackwelder, William C; Wu, Yukun; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma; Sow, Samba O; Ochieng, John B; Omore, Richard; Oundo, Joseph O; Breiman, Robert F; Mintz, Eric D; O'Reilly, Ciara E; Antonio, Martin; Saha, Debasish; Hossain, M Jahangir; Mandomando, Inacio; Bassat, Quique; Alonso, Pedro L; Ramamurthy, T; Sur, Dipika; Qureshi, Shahida; Zaidi, Anita K M; Hossain, Anowar; Faruque, Abu S G; Nataro, James P; Kotloff, Karen L; Levine, Myron M; Hinton, Jay C D; Tennant, Sharon M.
Afiliação
  • Kasumba IN; Center for Vaccine Development and Global Health.
  • Pulford CV; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Perez-Sepulveda BM; Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Sen S; Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Sayed N; Center for Vaccine Development and Global Health.
  • Permala-Booth J; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Livio S; Center for Vaccine Development and Global Health.
  • Heavens D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Low R; Center for Vaccine Development and Global Health.
  • Hall N; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Roose A; Center for Vaccine Development and Global Health.
  • Powell H; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Farag T; Earlham Institute, Norwich Research Park, Norwich, United Kingdom.
  • Panchalingham S; Earlham Institute, Norwich Research Park, Norwich, United Kingdom.
  • Berkeley L; Earlham Institute, Norwich Research Park, Norwich, United Kingdom.
  • Nasrin D; School of Biological Sciences, University of East Anglia, Norwich, United Kingdom.
  • Blackwelder WC; Center for Vaccine Development and Global Health.
  • Wu Y; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Tamboura B; Center for Vaccine Development and Global Health.
  • Sanogo D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Onwuchekwa U; Center for Vaccine Development and Global Health.
  • Sow SO; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Ochieng JB; Center for Vaccine Development and Global Health.
  • Omore R; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Oundo JO; Center for Vaccine Development and Global Health.
  • Breiman RF; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Mintz ED; Center for Vaccine Development and Global Health.
  • O'Reilly CE; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Antonio M; Center for Vaccine Development and Global Health.
  • Saha D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hossain MJ; Center for Vaccine Development and Global Health.
  • Mandomando I; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Bassat Q; Centre pour le Developpement des Vaccins, Bamako, Mali.
  • Alonso PL; Centre pour le Developpement des Vaccins, Bamako, Mali.
  • Ramamurthy T; Centre pour le Developpement des Vaccins, Bamako, Mali.
  • Sur D; Centre pour le Developpement des Vaccins, Bamako, Mali.
  • Qureshi S; Kenya Medical Research Institute/US Centers for Disease Control and Prevention, Kisumu, Kenya.
  • Zaidi AKM; Kenya Medical Research Institute/US Centers for Disease Control and Prevention, Kisumu, Kenya.
  • Hossain A; Kenya Medical Research Institute/US Centers for Disease Control and Prevention, Kisumu, Kenya.
  • Faruque ASG; Kenya Medical Research Institute/US Centers for Disease Control and Prevention, Kisumu, Kenya.
  • Nataro JP; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Kotloff KL; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Levine MM; Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
  • Hinton JCD; Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
  • Tennant SM; Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Clin Infect Dis ; 73(4): 631-641, 2021 08 16.
Article em En | MEDLINE | ID: mdl-33493332
ABSTRACT

BACKGROUND:

The Global Enteric Multicenter Study (GEMS) determined the etiologic agents of moderate-to-severe diarrhea (MSD) in children under 5 years old in Africa and Asia. Here, we describe the prevalence and antimicrobial susceptibility of nontyphoidal Salmonella (NTS) serovars in GEMS and examine the phylogenetics of Salmonella Typhimurium ST313 isolates.

METHODS:

Salmonella isolated from children with MSD or diarrhea-free controls were identified by classical clinical microbiology and serotyped using antisera and/or whole-genome sequence data. We evaluated antimicrobial susceptibility using the Kirby-Bauer disk-diffusion method. Salmonella Typhimurium sequence types were determined using multi-locus sequence typing, and whole-genome sequencing was performed to assess the phylogeny of ST313.

RESULTS:

Of 370 Salmonella-positive individuals, 190 (51.4%) were MSD cases and 180 (48.6%) were diarrhea-free controls. The most frequent Salmonella serovars identified were Salmonella Typhimurium, serogroup O8 (C2-C3), serogroup O6,7 (C1), Salmonella Paratyphi B Java, and serogroup O4 (B). The prevalence of NTS was low but similar across sites, regardless of age, and was similar among both cases and controls except in Kenya, where Salmonella Typhimurium was more commonly associated with cases than controls. Phylogenetic analysis showed that these Salmonella Typhimurium isolates, all ST313, were highly genetically related to isolates from controls. Generally, Salmonella isolates from Asia were resistant to ciprofloxacin and ceftriaxone, but African isolates were susceptible to these antibiotics.

CONCLUSIONS:

Our data confirm that NTS is prevalent, albeit at low levels, in Africa and South Asia. Our findings provide further evidence that multidrug-resistant Salmonella Typhimurium ST313 can be carried asymptomatically by humans in sub-Saharan Africa.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Salmonella Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Salmonella Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article